Therefore, risk factors linked to the etiology of basal‐like, HER2‐enriched and fast growing tumors would need to be pinpointed and taken into account in order for risk assessment tools to accurately predict risk to develop breast cancer, including the aggressive subtypes. This evidence concerns the gene ERBB2 and breast cancer.